IMMUNOCELLULAR THERAPEUTICS, LTD. INDEPENDENT DIRECTOR AGREEMENT Dated as of April 29, 2022Independent Director Agreement • August 10th, 2022 • ImmunoCellular Therapeutics, Ltd. • Pharmaceutical preparations • Arkansas
This Independent Director Agreement (this “Agreement”), dated and made effective as of the date first set forth above (the “Effective Date”), is entered into by and between ImmunoCellular Therapeutics, Ltd., a Delaware Corporation (“Company”), and ______________, an individual resident of the State of ____________ (“Director”). The Company and Director may be referred to herein individually as a “Party” or collectively as the “Parties”.
